CHANGES IN THE PHYSICAL AND NEUROPSYCHIATRIC STATUSES OF COVID-19 PATIENTS IN RESPONSE TO REHABILITATION

Abstract

Annotation: Relevance. Over 60% of patients who have undergone COVID-19 have serious physical and neuropsychiatric functional impairments both in the early and late periods after the acute phase of the disease. Target. The quality-of-life impairment in these patients provides a clear rationale for examining the effectiveness of rehabilitative treatment programs in these patients. Materials and methods. The study involved patients who have undergone COVID-19-associated pneumonia and have persistent disorders of physical neuropsychic status, and in general, deterioration in varying degrees of quality of life. Results.The inclusion of Derinat®, a solution of 15 mg / ml in outpatient medical organizations in the medical support of rehabilitation programs for patients with COVID-19 of varying severity, led to a reduction in the manifestations of physical status impairment; increasing endurance and reducing the recovery period during physical activity; reduction of symptoms of impaired neuropsychic status (disappearance of feelings of fatigue and anxiety),increasing appetite and improving the quality of personal care. Conclusions. Thus, a multidisciplinary approach to restorative treatment using a drug that stimulates regeneration and reparation causes positive changes in the quality of life of patients who have undergone COVID-19.